vs
Healthpeak Properties（DOC）与G III APPAREL GROUP LTD（GIII）财务数据对比。点击上方公司名可切换其他公司
G III APPAREL GROUP LTD的季度营收约是Healthpeak Properties的1.4倍（$988.6M vs $702.9M），Healthpeak Properties净利率更高（51.6% vs 8.2%，领先43.5%），Healthpeak Properties同比增速更快（-6.6% vs -9.0%），过去两年G III APPAREL GROUP LTD的营收复合增速更高（13.7% vs 0.5%）
Healthpeak Properties是美国医疗地产领域的房地产投资信托基金，核心投资范畴覆盖老年住宅、生命科学相关物业及医疗办公楼三类资产。公司2007年于马里兰州组建，总部设在科罗拉多州丹佛市，在尔湾、纳什维尔、旧金山均设有办事处，截至2019年12月31日共持有617处物业的权益。
GIII服装集团是一家国际时尚企业，设计、生产及销售服装、鞋履、配饰等产品，拥有多个知名自有及授权品牌，覆盖休闲、运动、轻奢等多个品类，主要销往北美、欧洲等全球市场，合作客户包括百货商场、专业零售商及电商平台。
DOC vs GIII — 直观对比
营收规模更大
GIII
是对方的1.4倍
$702.9M
营收增速更快
DOC
高出2.4%
-9.0%
净利率更高
DOC
高出43.5%
8.2%
两年增速更快
GIII
近两年复合增速
0.5%
损益表 — Q1 FY2026 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $702.9M | $988.6M |
| 净利润 | $363.0M | $80.6M |
| 毛利率 | — | 38.6% |
| 营业利润率 | 0.7% | 11.4% |
| 净利率 | 51.6% | 8.2% |
| 营收同比 | -6.6% | -9.0% |
| 净利润同比 | 28.3% | -29.8% |
| 每股收益（稀释后） | $0.28 | $1.84 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DOCGIII
| Q1 26 | $702.9M | — | ||
| Q4 25 | $719.4M | $988.6M | ||
| Q3 25 | $705.9M | $613.3M | ||
| Q2 25 | $694.3M | $583.6M | ||
| Q1 25 | $702.9M | $839.5M | ||
| Q4 24 | $698.0M | $1.1B | ||
| Q3 24 | $700.4M | $644.8M | ||
| Q2 24 | $695.5M | $609.7M |
净利润DOCGIII
| Q1 26 | $363.0M | — | ||
| Q4 25 | $114.0M | $80.6M | ||
| Q3 25 | $-117.1M | $10.9M | ||
| Q2 25 | $31.7M | $7.8M | ||
| Q1 25 | $42.8M | $48.8M | ||
| Q4 24 | $4.5M | $114.8M | ||
| Q3 24 | $85.9M | $24.2M | ||
| Q2 24 | $146.0M | $5.8M |
毛利率DOCGIII
| Q1 26 | — | — | ||
| Q4 25 | — | 38.6% | ||
| Q3 25 | 58.6% | 40.8% | ||
| Q2 25 | 60.2% | 42.2% | ||
| Q1 25 | 61.1% | 39.5% | ||
| Q4 24 | 60.3% | 39.8% | ||
| Q3 24 | 60.0% | 42.8% | ||
| Q2 24 | 60.6% | 42.5% |
营业利润率DOCGIII
| Q1 26 | 0.7% | — | ||
| Q4 25 | 17.4% | 11.4% | ||
| Q3 25 | 9.2% | 2.7% | ||
| Q2 25 | 5.7% | 1.5% | ||
| Q1 25 | 7.7% | 8.5% | ||
| Q4 24 | -2.2% | 15.3% | ||
| Q3 24 | 14.1% | 6.4% | ||
| Q2 24 | 22.3% | 2.2% |
净利率DOCGIII
| Q1 26 | 51.6% | — | ||
| Q4 25 | 73.2% | 8.2% | ||
| Q3 25 | -16.6% | 1.8% | ||
| Q2 25 | 4.6% | 1.3% | ||
| Q1 25 | 6.1% | 5.8% | ||
| Q4 24 | 0.7% | 10.6% | ||
| Q3 24 | 12.3% | 3.8% | ||
| Q2 24 | 21.0% | 1.0% |
每股收益（稀释后）DOCGIII
| Q1 26 | $0.28 | — | ||
| Q4 25 | $0.16 | $1.84 | ||
| Q3 25 | $-0.17 | $0.25 | ||
| Q2 25 | $0.05 | $0.17 | ||
| Q1 25 | $0.06 | $1.00 | ||
| Q4 24 | $0.02 | $2.55 | ||
| Q3 24 | $0.12 | $0.53 | ||
| Q2 24 | $0.21 | $0.12 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $-1.2B | $184.1M |
| 总债务越低越好 | — | $6.5M |
| 股东权益账面价值 | $7.8B | $1.8B |
| 总资产 | $21.6B | $2.8B |
| 负债/权益比越低杠杆越低 | — | 0.00× |
8季度趋势，按日历期对齐
现金及短期投资DOCGIII
| Q1 26 | $-1.2B | — | ||
| Q4 25 | $467.5M | $184.1M | ||
| Q3 25 | $91.0M | $301.8M | ||
| Q2 25 | $89.4M | $257.8M | ||
| Q1 25 | $70.6M | $181.4M | ||
| Q4 24 | $119.8M | $104.7M | ||
| Q3 24 | $180.4M | $414.8M | ||
| Q2 24 | $106.9M | $508.4M |
总债务DOCGIII
| Q1 26 | — | — | ||
| Q4 25 | $9.8B | $6.5M | ||
| Q3 25 | $9.1B | $6.9M | ||
| Q2 25 | $9.0B | $6.8M | ||
| Q1 25 | $8.9B | $3.0M | ||
| Q4 24 | $8.7B | $213.9M | ||
| Q3 24 | $8.6B | $402.5M | ||
| Q2 24 | $8.6B | $402.7M |
股东权益DOCGIII
| Q1 26 | $7.8B | — | ||
| Q4 25 | $7.5B | $1.8B | ||
| Q3 25 | $7.6B | $1.7B | ||
| Q2 25 | $7.9B | $1.7B | ||
| Q1 25 | $8.2B | $1.7B | ||
| Q4 24 | $8.4B | $1.6B | ||
| Q3 24 | $8.6B | $1.5B | ||
| Q2 24 | $8.8B | $1.5B |
总资产DOCGIII
| Q1 26 | $21.6B | — | ||
| Q4 25 | $20.3B | $2.8B | ||
| Q3 25 | $19.6B | $2.7B | ||
| Q2 25 | $19.8B | $2.4B | ||
| Q1 25 | $19.8B | $2.5B | ||
| Q4 24 | $19.9B | $2.8B | ||
| Q3 24 | $20.0B | $2.7B | ||
| Q2 24 | $20.2B | $2.6B |
负债/权益比DOCGIII
| Q1 26 | — | — | ||
| Q4 25 | 1.31× | 0.00× | ||
| Q3 25 | 1.20× | 0.00× | ||
| Q2 25 | 1.14× | 0.00× | ||
| Q1 25 | 1.08× | 0.00× | ||
| Q4 24 | 1.04× | 0.13× | ||
| Q3 24 | 1.00× | 0.27× | ||
| Q2 24 | 0.98× | 0.26× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $-97.3M |
| 自由现金流经营现金流 - 资本支出 | — | $-106.4M |
| 自由现金流率自由现金流/营收 | — | -10.8% |
| 资本支出强度资本支出/营收 | 3.4% | 0.9% |
| 现金转化率经营现金流/净利润 | — | -1.21× |
| 过去12个月自由现金流最近4个季度 | — | $367.7M |
8季度趋势，按日历期对齐
经营现金流DOCGIII
| Q1 26 | — | — | ||
| Q4 25 | $1.3B | $-97.3M | ||
| Q3 25 | $315.0M | $75.1M | ||
| Q2 25 | $363.5M | $93.8M | ||
| Q1 25 | $279.4M | $333.4M | ||
| Q4 24 | $1.1B | $-111.8M | ||
| Q3 24 | $318.2M | $49.3M | ||
| Q2 24 | $316.2M | $45.5M |
自由现金流DOCGIII
| Q1 26 | — | — | ||
| Q4 25 | $357.0M | $-106.4M | ||
| Q3 25 | — | $64.7M | ||
| Q2 25 | — | $85.7M | ||
| Q1 25 | — | $323.7M | ||
| Q4 24 | $333.7M | $-120.3M | ||
| Q3 24 | — | $38.8M | ||
| Q2 24 | — | $32.8M |
自由现金流率DOCGIII
| Q1 26 | — | — | ||
| Q4 25 | 49.6% | -10.8% | ||
| Q3 25 | — | 10.6% | ||
| Q2 25 | — | 14.7% | ||
| Q1 25 | — | 38.6% | ||
| Q4 24 | 47.8% | -11.1% | ||
| Q3 24 | — | 6.0% | ||
| Q2 24 | — | 5.4% |
资本支出强度DOCGIII
| Q1 26 | 3.4% | — | ||
| Q4 25 | 124.4% | 0.9% | ||
| Q3 25 | — | 1.7% | ||
| Q2 25 | — | 1.4% | ||
| Q1 25 | — | 1.2% | ||
| Q4 24 | 105.6% | 0.8% | ||
| Q3 24 | — | 1.6% | ||
| Q2 24 | — | 2.1% |
现金转化率DOCGIII
| Q1 26 | — | — | ||
| Q4 25 | 10.99× | -1.21× | ||
| Q3 25 | — | 6.86× | ||
| Q2 25 | 11.48× | 12.09× | ||
| Q1 25 | 6.52× | 6.83× | ||
| Q4 24 | 235.43× | -0.97× | ||
| Q3 24 | 3.71× | 2.04× | ||
| Q2 24 | 2.17× | 7.84× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DOC
| Outpatient Medical | $320.5M | 46% |
| Lab | $217.6M | 31% |
| Senior Housing | $148.9M | 21% |
| Other | $14.3M | 2% |
| Corporate Non-segment | $1.5M | 0% |
GIII
| Proprietary Brands | $498.1M | 50% |
| Licensed Brands | $479.2M | 48% |
| Retail Segment | $45.7M | 5% |
